期刊文献+

重组脑利钠肽治疗对急性心肌梗死大鼠心功能的影响 被引量:4

Effects of brain natriuretic peptide on cardiac function of rats with acute myocardial infarction
下载PDF
导出
摘要 目的:探讨早期重组人脑利钠肽(rhBNP)治疗对大鼠急性心肌梗死(AMI)后心功能的影响。方法:结扎大鼠左前降支,建立AMI模型,存活的大鼠被随机分为AMI对照组(20只)和rhBNP治疗组(20只),另设假手术组(15只)。rhBNP治疗组给予1周BNP治疗,AMI对照组和假手术组仅以等体积生理盐水静脉注射,2周后观察rhBNP对心功能的影响。结果:与假手术组相比,AMI对照组左室舒张末期内径(LVEDd)明显增加[(4.4±0.3)mm比(7.7±0.3)mm],左室射血分数[LVEF,(82±5)%比(42±10)%]和左室短轴缩短率[FS,(50±5)%比(18±6)%]明显减少(P<0.05);经BNP治疗后,BNP组LVEDd[(6.4±0.4)mm]、LVEF[(51±7)%]、FS[(29±7)%]均较AMI对照组明显改善(P<0.05)。结论:早期重组人脑利钠肽治疗急性心肌梗死可以有效改善心脏功能。 Objective:To explore effects of early recombinant human brain natriuretic peptide(rhBNP) treatment on cardiac function of rats after acute myocardial infarction(AMI).Methods:AMI model was established by ligating left anterior descending artery of rats.Survived rats were randomly divided into AMI control group(n=20) and rhBNP treatment group(n=20),and another 15 normal rats were enrolled as sham operation group.Rats in rhBNP treatment group were treated with rhBNP for a week,and AMI control group,sham operation group were treated with intravenous injection of physiological saline of same volume.Effects of rhBNP on cardiac function were observed and analyzed after two weeks.Results:Compared with sham operation group,left ventricular end-diastolic dimension [LVEDd,(4.4±0.3)mm vs.(7.7±0.3)mm] significantly increased,left ventricular ejection infraction [LVEF,(82±5)% vs.(42±10)%] and fractional shortening [FS,(50±5)% vs.(18±6)%] significantly decreased in AMI control group(P〈0.05);After treated with rhBNP,LVEDd [(6.4±0.4)mm],LVEF[(51±7)%] and FS[(29±7)%] significantly improved in rhBNP treatment group compared with AMI control group(P〈0.05).Conclusion:Early treatment with recombinant human brain natriuretic peptide can effectively improve cardiac function in rats with acute myocardial infarction.
出处 《心血管康复医学杂志》 CAS 2011年第4期367-368,共2页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心肌梗塞 利钠肽 心室功能 Myocardial infarction Natriuretic peptide brain Ventricular function
  • 相关文献

参考文献5

二级参考文献35

  • 1郭文安,杜心清.基质金属蛋白酶及其抑制物表达平衡失调与心肌梗塞后心室重塑[J].心血管康复医学杂志,2007,16(3):302-305. 被引量:12
  • 2Horio T,Kohno M,Takeda T.Effects of arginine vasopressin angiotensin Ⅱand endothelin-Ⅰ on the release of brain natriuretic peptide in vivo and in vitro[J].Clin Exp Pharmacol Physiol,1992,19(8):575-582.
  • 3Wiezorek SJ,Wu AH,Christensen R,et al.A rapid B-type natriurctie peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation[J].Am Heart J,2002,144:834-839.
  • 4Etoh T, Joffs C, Deschamps AM, et al.Myocardial and interstitial matrix metalloproteinase activity after acute myocardial infarction in pigs[J].Am J Physiol Heart Circ Physiol, 2001, 281(3): 987-994.
  • 5de Bold AJ,Bruneau BG,de Bold KML.Mechanical and neuroendocrine regulation of the endocrine heart[J].Cardiovasc Res,1996,31:7-18.
  • 6Lainchbury JG,Nicholls MG,Espiner EA,et al.Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man[J].Clin Sci,1998,95:547-555.
  • 7Tamura N,Ogawa Y,Chusho H,et al.Cardiac fibrosis in mice lacking brain natriuretic peptide[J].Proc Natl Acad Sci USA,2000,97(8):4239-4244.
  • 8Yoshizumi M,Tsuji H,Nishimura H,et al.Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells[J].Thromb Haemost,1999,82:1497-1503.
  • 9Morrison LK,Harrison A,Krishnaswamy P,et al.Utility of a rapid brain natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea[J].J Am Coll Cardiol,2002,39:202-209.
  • 10Davis M,Espiner E,Richards G,et al.Plasma brain natriuretic peptide in assessment of acute dyspnoea[J].Lancet,1994,343:440-444.

共引文献63

同被引文献34

  • 1夏治民,蒋文新,叶绗.慢性心力衰竭血浆B型利钠肽监测239例临床分析[J].临床医药实践,2007,16(5):339-341. 被引量:13
  • 2Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemo- dynamic, neurohormonal, and renal effects of a steadystate infu- sion of human brain natriuretic peptide in patients with hemody- namically decompensated heart failure [J]. J Card Fail, 1998, 4 (1) :37- 44.
  • 3Kawakami R, Saito Y, Kishimoto I, et al. Overexpression ofbrain natriuretic peptide facilitates neutrophil infiltration and car- diac matrix metalloproteinase- 9 expression after acute myocardi- al infarction [J-]. Circulation, 2004, 110 (21): 3306-3312.
  • 4Keating GM, Goa KL. Nesiritide.- a review of its use in acute decompensated heart failure [J]. Drugs, 2003, 63 (1): 47-70.
  • 5Strain WD. The use of recombinant human B-type natriutetic peptide (nesiritide) in the management of acute decompensated heart failure [J]. Int J Clin Pract, 2004, 58 (11):1081-1087.
  • 6Moe GW, Howlett J, Januzzi JL. Response to Letter Regarding Article, "N-Terminal Pro-IB-Type Natriuretic Peptide Tes ting Improves the Management of Patients With Suspected Acute Heart Failure: Primary results of the Canadian Prospective Ran- domized Multieenter IMPROVE-CHF Study" [J]. Circulation, 2008, 117 (1): e6.
  • 7Publication Committee for the VMAC Investigators vasalilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure:a randomized controlled trial[J].Journal of the American Medical Association,2002,(12):1531-1540.
  • 8Aronson D,Burger AJ. Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure[J].American Journal of Cardiology,2002,(04):435-438.
  • 9Berendes E,Schmidt C,Van Aken H. A-type and B-type natriuretic peptides in cardiac surgical procedures[J].Anesthesia and Analgesia,2004,(01):11-19.
  • 10Fisher C,Berry C,Blue L. N-terminal proB type natriuretic peptide,but not the new putative cardiac hormone relaxin,predicts prognosis in patients with chronic heart failure[J].Heart,2003,(08):879-881.doi:10.1136/heart.89.8.879.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部